[Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine].
Pradalier
A
A
Dry
J
J
Loisy
B
B
Meininger
V
V
Vicaut
E
E
Mirabaud
C
C
Levy
M
M
D000328:Adult; D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007217:Indoramin / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D013997:Time Factors
D007211:Indoles; D007217:Indoramin; D004087:Dihydroergotamine
Etude comparative indoramine versus dihydroergotamine dans le traitement préventif de la migraine.